InvestorsHub Logo
Followers 17
Posts 10849
Boards Moderated 0
Alias Born 03/11/2017

Re: None

Monday, 01/08/2024 4:03:38 PM

Monday, January 08, 2024 4:03:38 PM

Post# of 44784
PluriCDMO™ will offer its unique knowledge and technology and over 20 years of
development and manufacturing experience. Its state-of-the-art 47 thousand square foot Good Manufacturing Practice (GMP) cell therapy production facility is expected to help customers and PARTNERS address key challenges in the development and manufacturing of cell-based therapies.
Bullish
Bullish